ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY™ Prostate Cancer Screening Platform
“LONDON, U.K. — April 2, 2019 — Based on its recent analysis of the European prostate cancer screening market, Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.” Follow this link to the press release
STOCKHOLM – March 28, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the signing of an agreement which opens up for several new research projects within digital pathology, based on cleaned and structured data from a large Biobank. With more than six million human specimens – […]
STOCKHOLM – 27. of March 2019 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, is pleased to announce that Fredrik Palm will become CEO of the Company as of April 1, 2019. Fredrik Palm has since 2012 been the Company’s V.P. of sales and was instrumental in growing sales significantly under his […]
March 11st, 2019 – An article about ContextVision has been published in the Norwegian business newspaper Finansavisen (in Norwegian only). Please find a link here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43
Today ContextVision held a company presentation at Danske Bank's Small & Mid Cap Seminar in Stockholm, Sweden.CEO Anita Tollstadius gave an update of the company's development and shared the company's future direction.
Stockholm, February 28th, 2019 – Today ContextVision held a company presentation in Oslo, Norway. The arrangement was held at Norne Securities AS premises at Roald Amundsens gt. 6, Oslo. Anita Tollstadius gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will […]
STOCKHOLM – February 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is closing in on a commercial product within digital pathology with a planned launch in 2019. Tests prove that ContextVision’s algorithms perform as well as pathologists and have also helped identify suspicious cancer areas that are […]